Posted on

Lung Tissue Arrays

Please send your request for detailed information and quote to: info@vitrovivo.com

SKU#

DESCRIPTION

CASE

 CORE

PRICE ($)

LC816 Different stages of lung cancer and lung tissue array, including pathology grade, TNM and cinical stage (small cell carcinoma reference AJCC 8th edition), 80 cases/80 cores 80 80 331.50
RLC-820 Early stage of lung cancer with lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 40 cases/80 cores 40 80 331.50
LC2086b High density lung tissue array, 96 cases/192 cores, replacing LC2086a 96 192 513.50
LC2085a High-density lung cancer (1-3 grade) tissue array with normal lung tissue, including pathology grade and TNM, 188 cases/208 cores 188 208 591.50
LC2085c High-density lung cancer tissue array with normal and cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 186 cases/208 cores, replacing LC2085b 186 208 591.50
RLN701 Lung adjacent normal tissue array, 72 cases/72 cores  72 72 292.50
RLC-821 Lung cancer and lung tissue array with smoking history (2015 WHO classification), including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 40 cases/80 cores 40 80 331.50
LC20818 Lung cancer and lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 208 cases/208 cores 208 208 591.50
LC1004 Lung cancer and lung tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores 50 100 292.50
LC1005a Lung cancer progression tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing LC1005 100 100 292.50
T046 Lung cancer test tissue array (4x (2×3)array) including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 52.00
LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
LC20813b Lung cancer tissue array (2 of 5), including pathology grade, TNM and clinical stage, 192 cases/192 cores, replacing LC20813a 208 208 591.50
LC20814 Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
LC20815 Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
LC20816 Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
RLC-04081a Lung cancer tissue array with adjacent lung tissue, including pathology grade, TNM and clinical stage, 21 cases/63 cores, replacing BS04081 21 63 149.5
LC241h Lung cancer tissue array with matched adjacent normal lung tissue, including TNM and pathology grade, 6 cases/24 cores, replacing LC241g 6 24 52.00
LC241g Lung cancer tissue array with matched adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 6 cases/ 24 cores, replaced by LC241h 6 24 52.00
LC241j Lung cancer tissue array with matched adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing LC241i 6 24 52.00
RLC-241m Lung cancer tissue array with matched cancer adjacent lung tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing LC241l 6 24 71.50
LC10010c Lung cancer tissue array with normal lung tissue, including TNM and clinical stage, 50 cases/100 cores, replacing LC10010b 50 100 331.50
LC803 Lung cancer tissue array with normal tissue, including pathology grade, 80 cases/80 cores 80 80 253.50
LC961 Lung cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 48 cases/96 cores 48 96 279.50
T045e Lung cancer tissue array, including pathology grade, TNM and clinical stage, 12 cases/ 24 cores, replacing T045d 6 24 52.00
LC20817 Lung cancer tissue array, including pathology grade, TNM and clinical stage, 208 cases/208 cores 208 208 591.50
RLC-04017c Lung cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores 48 96 292.5
VLC12a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/ 12 cores, replacing VLC12 12 12 71.50
LC962 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores, replacing LUC962 48 96 279.50
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores 75 150 331.50
LC819 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores 80 80 331.50
LC724 Lung cancer with adjacent normal tissue array, including TNM, clinical stage and pathology grade, 24 cases/72 cores 24 72 292.50
RLC-243a Lung cancer with lung tissue array (2015 WHOclassification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 2 serial sections, 24 cases/48 cores, replacing LC243 24 48 71.50
LC485a Lung cancer with lung tissue array, including pathology grade, TNM and clinical satge, 48 cases/48 cores, replacing LC485 48 48 214.5
LC811b Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (8th edition of AJCC), 80 cases/80 cores, replacing LC811a 80 80 292.5
T041a Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 6 cases/24 cores, replacing T041 6 24 52.00
RLC-041115e Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage, 120 cases/120 cores 120 120 331.50
LC241c Lung cancer with matched lung tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replaced by LC241d 6 24 52.00
LC241k Lung cancer with matched lung tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing LC241j 6 24 52.00
LC814b Lung cancer with matched lymph node metastasis carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing LC814a 40 80 331.50
LC817a Lung cancer with matched lymph node metastasis tissue array, including TNM and pathology grade, 40 cases/80 cores, replacing LC817 40 80 279.50
LC702 Lung cancer with necrosis tissue array, including TNM, clinical stage and pathology grade, 30 cases/30 cores 30 30 253.50
T043a Lung cancer with normal lung tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T043 6 24 71.50
LC805 Lung large cell cancer and adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores 40 80 240.50
LC705 Lung mucinous adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 21 cases/21 cores 21 21 292.50
LC489 Lung non-small cell cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 48 48 214.50
LC10011a Lung non-small cell carcinoma tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replaced by LC10011b 50 100 331.50
LC10012c Lung non-small cell carcinoma with lung tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing LC10012b 50 100 331.50
LC703b Lung small cell cancer tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition), 44 cases/44 cores, replacing LC703a 44 44 292.50
LC818b Lung small cell cancer tissue array, including TNM and clinical stage (AJCC 8th edition), 80 cases/80 cores, replacing LC818a 80 80 331.50
RLC-10015b Lung squamous cell carcinoma tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/100 cores, replacing LC10015a 50 100 448.50
LC642a Lung squamous cell carcinoma tissue array, including pathology grade, TNM and clinical stage, 64 cases/64 cores, replacing LC642 64 64 214.50
LC991 Lung squamous cell carcinoma with matched lung tissue array, including pathology grade, TNM and clinical stage, 33 cases/99 cores 33 99 292.50
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores 104 208 513.50
LC2088 Lung tumor survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores 104 208 513.50
LC2089 Lung tumor survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores 104 208 513.50
LC20810 Lung tumor survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores 104 208 513.50
LC20811 Lung tumor survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores 104 208 513.50
LC1922a Middle-advanced stage lung non-small cell cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores, replacing LC1922 96 192 643.50
RLC-485a Multiple lung cancer with lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 48 cases/48 cores, replacing LC485 48 48 175.50
LC1201a Multiple lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th), 118 cases/120 cores, replacing LC1201 118 120 331.50
LUN502 Multiple lung cancer with matched adjacent normal lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 25 cases/50 cores 50 50 175.50
RLN241a Normal lung tissue array, 24 cases/24 cores, replacing LCN241 24 24 214.50
RLN401b PD-L1 tested non-small cell lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1 (Sp263) results, 40 cases/40 core, replacing LC401a 40 40 292.50
RLN401c PD-L1 tested non-small cell lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1 (Sp263) results, 40 cases/40 core, replacing RLN401b 40 40 292.50
LC401 PD-L1 tested non-small cell lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1(Sp263) information, 40 cases/40 core 40 40 331.50
LC04a PD-L1 tested non-small cell lung cancer tissue array, which is suitable for tumor immunotherapy, including pathology grade, TNM, clinical stage and PD-L1(Sp263) information, 4 cases/4 core, replacing LC04 4 4 71.50
LC10013b Lung adenocarcinoma tissue array with matched normal lung tissue, including pathology grade, TNM and clinical stage, 52 cases/100 cores, replacing LC10013a 52 100 331.50
LC641a Lung adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 64 cases/64 cores, LC641 64 64 214.50
RLC-641a Lung adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 64 cases/64 cores, relacing LC641 64 64 214.50
LC706a Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 75 cases/75 cores, replacing LC706 75 75 331.50
LUN501 Lung adenocarcinoma with lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores 50 50 175.50
T047b Non-small cell lung cancer test tissue array including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T047a 6 24 71.50
RLC-047b Non-small cell lung cancer test tissue array,including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T047a 6 24 52.00
LC121c Non-small cell lung cancer tissue array, including pathology grade, TNM and clinical stage, 120 cases/120 cores, replacing LC121b 120 120 448.50
LC121d Non-small cell lung cancer tissue array, including pathology grade, TNM and clinical stage, 120 cases/120 cores, replacing LC121c 120 120 448.50
LC242a Non-small cell lung carcinoma tissue array with normal tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 12 cases/24 cores, replaced by LC242b 12 24 71.50

TMA Applications:

Routine histology procedures including immunohistochemistry (IHC) and in situ hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.